These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 17021752)

  • 1. D2-40 functions as an effective chondroid marker distinguishing true chondroid tumors from chordoma.
    Huse JT; Pasha TL; Zhang PJ
    Acta Neuropathol; 2007 Jan; 113(1):87-94. PubMed ID: 17021752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
    Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
    Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical distinction of classic and chondroid chordomas.
    Walker WP; Landas SK; Bromley CM; Sturm MT
    Mod Pathol; 1991 Sep; 4(5):661-6. PubMed ID: 1722044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical comparison of chordoma with chondrosarcoma, myxopapillary ependymoma, and chordoid meningioma.
    Cho HY; Lee M; Takei H; Dancer J; Ro JY; Zhai QJ
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):131-8. PubMed ID: 19521276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical and ultrastructural study of skull base chordomas.
    Kubota T; Sato K; Kabuto M; Kawano H; Nakagawa T; Arai Y; Tachibana O; Yoshida K; Yamashita J
    Noshuyo Byori; 1994; 11(1):23-8. PubMed ID: 7512866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroid chordomas and low-grade chondrosarcomas of the craniospinal axis. An immunohistochemical analysis of 17 cases.
    Wojno KJ; Hruban RH; Garin-Chesa P; Huvos AG
    Am J Surg Pathol; 1992 Dec; 16(12):1144-52. PubMed ID: 1463093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40.
    Daugaard S; Christensen LH; Høgdall E
    APMIS; 2009 Jul; 117(7):518-25. PubMed ID: 19594492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chondroid chordoma of the sacrococcygeal region.
    Chu TA
    Arch Pathol Lab Med; 1987 Sep; 111(9):861-4. PubMed ID: 2443106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chordoma. An immunohistochemical study of 20 cases.
    Meis JM; Giraldo AA
    Arch Pathol Lab Med; 1988 May; 112(5):553-6. PubMed ID: 2451900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reassessment of "chordoid sarcoma". Ultrastructural and immunohistochemical comparison with chordoma and skeletal myxoid chondrosarcoma.
    Wick MR; Burgess JH; Manivel JC
    Mod Pathol; 1988 Nov; 1(6):433-43. PubMed ID: 2464825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
    Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
    Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroid chordoma--a variant of chordoma. A morphologic and immunohistochemical study.
    Rosenberg AE; Brown GA; Bhan AK; Lee JM
    Am J Clin Pathol; 1994 Jan; 101(1):36-41. PubMed ID: 7506477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors.
    Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M
    Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondroid chordoma. A hyalinized chordoma without cartilaginous differentiation.
    Jeffrey PB; Biava CG; Davis RL
    Am J Clin Pathol; 1995 Mar; 103(3):271-9. PubMed ID: 7532910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of myxoid bone tumors of the skull base].
    Gavril C; Bouvier C; Liprandi A; Dufour H; Peragut JC; Zanaret M; Figarella-Branger D
    Ann Pathol; 2002 Sep; 22(4):259-66. PubMed ID: 12410148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
    J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachyury expression in extra-axial skeletal and soft tissue chordomas: a marker that distinguishes chordoma from mixed tumor/myoepithelioma/parachordoma in soft tissue.
    Tirabosco R; Mangham DC; Rosenberg AE; Vujovic S; Bousdras K; Pizzolitto S; De Maglio G; den Bakker MA; Di Francesco L; Kalil RK; Athanasou NA; O'Donnell P; McCarthy EF; Flanagan AM
    Am J Surg Pathol; 2008 Apr; 32(4):572-80. PubMed ID: 18301055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications.
    Hruban RH; Traganos F; Reuter VE; Huvos AG
    Am J Pathol; 1990 Aug; 137(2):435-47. PubMed ID: 1696786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbon ion radiotherapy for chordomas and low-grade chondrosarcomas of the skull base. Results in 67 patients.
    Schulz-Ertner D; Nikoghosyan A; Thilmann C; Haberer T; Jäkel O; Karger C; Scholz M; Kraft G; Wannenmacher M; Debus J
    Strahlenther Onkol; 2003 Sep; 179(9):598-605. PubMed ID: 14628125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chondrosarcoma is not characterized by detectable telomerase activity.
    Bovée JV; van Den Broek LJ; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2001 Mar; 193(3):354-60. PubMed ID: 11241416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.